EP Patent

EP0911327A1 — Novel pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient

Assigned to Wakunaga Pharmaceutical Co Ltd · Expires 1999-04-28 · 27y expired

What this patent protects

A pyridonecarboxylic acid derivative represented by the following general formula (1): [wherein R 1 represents hydrogen atom or a carboxyl protective group; R 2 represents hydroxyl group, a lower alkoxy group, or a substituted or unsubstituted amino group; R 3 represents hyd…

USPTO Abstract

A pyridonecarboxylic acid derivative represented by the following general formula (1): [wherein R 1 represents hydrogen atom or a carboxyl protective group; R 2 represents hydroxyl group, a lower alkoxy group, or a substituted or unsubstituted amino group; R 3 represents hydrogen atom or a halogen atom; R 4 represents hydrogen atom or a halogen atom; R 5 represents a halogen atom or an optionally substituted saturated cyclic amino group; R 6 represents hydrogen atom, a halogen atom, nitro group, or an optionally protected amino group; X, Y and Z may be the same or different and respectively represent nitrogen atom, -CH= or -CR 7 = (wherein R 7 represents a lower alkyl group, a halogen atom, or cyano group) (with the proviso that at least one of X, Y and Z represent the nitrogen atom), and W represents nitrogen atom or -CR 8 = (wherein R 8 represents hydrogen atom, a halogen atom, or a lower alkyl group)] or its salt, as well as an antibacterial agent containing such compound are provided.

Drugs covered by this patent

Patent Metadata

Patent number
EP0911327A1
Jurisdiction
EP
Classification
Expires
1999-04-28
Drug substance claim
No
Drug product claim
No
Assignee
Wakunaga Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.